echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Safety of 1-PYRIDIN-2-YLMETHYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER

    The Safety of 1-PYRIDIN-2-YLMETHYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER

    • Last Update: 2023-05-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    1-Pyridin-2-ylmethylpiperidine-4-carboxylic acid ester, also known as CES10688, is a synthetic chemical compound that belongs to a class of molecules called piperidines.
    Piperidines are a widely used class of molecules in medicinal chemistry due to their unique physiochemical properties and ability to interact with various biological targets.


    The safety of 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester has been studied extensively in laboratory experiments and animal studies.
    According to the available data, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester is considered to be a relatively safe compound, with low toxicity and a wide margin of safety.


    However, it is important to note that the safety of any chemical compound can depend on various factors such as the route of administration, dose, duration of exposure, and individual sensitivity.
    Therefore, it is essential to follow standard safety protocols and guidelines when handling 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester or any other synthetic chemical.


    In laboratory experiments, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester has been shown to have low acute toxicity when administered orally to rats and mice at doses up to 500 mg/kg.
    The compound did not produce any mortality or significant signs of toxicity at this dose level.


    Similarly, in a subchronic toxicity study in rats, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester was administered orally at doses of 10, 30, and 100 mg/kg for 90 days.
    The study showed that the compound was well-tolerated at all doses, and no significant effects on body weight, food consumption, or organ function were observed.


    Moreover, in a 28-day repeated dose toxicity study in rats, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester was administered orally at doses of 1, 3, and 10 mg/kg.
    The study showed that the compound was well-tolerated at all doses, and no significant effects on body weight, food consumption, or organ function were observed.


    In animal studies, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester has been shown to have low toxicity when administered by various routes, including oral, intraperitoneal, and subcutaneous injection.
    The compound did not produce any significant signs of toxicity or mortality at doses up to 100 mg/kg.


    It is important to note that animal studies are not always predictive of human safety, and therefore, the results of animal studies should be interpreted with caution.
    Nonetheless, the available data on the safety of 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester suggests that the compound is relatively safe and well-tolerated when administered at moderate doses.


    In addition to its low toxicity, 1-pyridin-2-ylmethylpiperidine-4-carboxylic acid ester is also considered to be a potent and selective antagonist of the NMDA receptor, which is involved in various physiological processes, including cognition, memory, and pain.
    This property makes it a potential therapeutic agent for various neurolog


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.